Expert Illustrations & Commentaries™: Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?
Released On
February 17, 2023
Expires On
February 17, 2024
Media Type
Internet
Completion Time
90 minutes
Specialty
Psychiatry
Topic(s)
New drugs, Schizophrenia
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by educational grants from Otsuka and Sunovion.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Nurses — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is directed toward an audience of psychiatrists, nurse practitioners, physician assistants, and other health care practitioners involved in the treatment of schizophrenia.
Activity Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss strategies for antipsychotic management of schizophrenia. In this activity, the faculty focus on the pathophysiology of schizophrenia and ways that current and emerging antipsychotic therapies target the pathophysiologic processes at play, particularly trace amine-associated receptor 1 (TAAR1) activity. The faculty discussion is enriched with the use of video animation to illustrate the role of TAAR1. The use of animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the treatment of patients with schizophrenia.
Learning Objectives
- Explain the role of the TAAR1 in schizophrenia, with a focus on the mechanisms of action of TAAR1 agonists.
- Evaluate clinical trial data for new and emerging agents for the treatment of patients with schizophrenia.
- Formulate individualized treatment plans for patients with schizophrenia.
Faculty
John J. Miller, MD
Medical Director, Brain Health
Editor in Chief, Psychiatric Times®
Staff Psychiatrist, Seacoast Mental Health Center
Consulting Psychiatrist, Exeter Hospital
Exeter, NH
Consulting Psychiatrist, Insight Meditation Society
Barre, MA
Sanjai Rao, MD
Clinical Professor
Associate Residency Training Director
Department of Psychiatry
University of California, San Diego
Site Director, Residency Training
VA San Diego Healthcare System
San Diego, CA
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- John J. Miller, MD
- Consultant: Intracellular, Karuma, Sunovion
- Speakers’ Bureau: AbbVie, Axsome, Intracellular, Janssen, Neurocrine, Otsuka/Lundbeck, Sunovion, Teva
- Sanjai Rao, MD
- Speakers’ Bureau: Alkermes, Janssen, Neurocrine, Otsuka
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.